Spouting Rock Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,346
Closed -$453K 162
2022
Q3
$453K Sell
10,346
-4,300
-29% -$209K 0.35% 84
2022
Q2
$768K Sell
14,646
-7,164
-33% -$365K 0.5% 62
2022
Q1
$1.13M Sell
21,810
-5,400
-20% -$280K 0.94% 37
2021
Q4
$1.61M Sell
27,210
-13,720
-34% -$680K 1.26% 34
2021
Q3
$1.76M Buy
40,930
+17,016
+71% +$754K 0.88% 46
2021
Q2
$936K Buy
+23,914
New +$930K 0.29% 115

Other funds holding PFE

Spouting Rock Asset Management's PFE Position: Q4 2022 in Review

Spouting Rock Asset Management sold out of Pfizer (PFE) in Q4 2022, closing a stake of 10,346 shares — an estimated $453K sold.

Spouting Rock Asset Management first reported a position in PFE in Q2 2021 and held it in 6 quarters. The position peaked at $1.76M in Q3 2021. 3,265 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

  • Spouting Rock Asset Management reported no remaining Pfizer position as of Q4 2022 after selling out during the quarter.
  • Spouting Rock Asset Management sold 10,346 Pfizer shares in Q4 2022, an estimated $453K.
  • Spouting Rock Asset Management first reported a position in Pfizer in Q2 2021 and held it in 6 quarters.
  • Spouting Rock Asset Management's Pfizer position peaked at $1.76M in Q3 2021.
  • 3,265 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on Spouting Rock Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.